LLY

1,043.44

-0.5%↓

JNJ

244.93

-0.74%↓

ABBV

231.82

+1.2%↑

NVS

167.49

+0.26%↑

MRK

123.99

+0.36%↑

LLY

1,043.44

-0.5%↓

JNJ

244.93

-0.74%↓

ABBV

231.82

+1.2%↑

NVS

167.49

+0.26%↑

MRK

123.99

+0.36%↑

LLY

1,043.44

-0.5%↓

JNJ

244.93

-0.74%↓

ABBV

231.82

+1.2%↑

NVS

167.49

+0.26%↑

MRK

123.99

+0.36%↑

LLY

1,043.44

-0.5%↓

JNJ

244.93

-0.74%↓

ABBV

231.82

+1.2%↑

NVS

167.49

+0.26%↑

MRK

123.99

+0.36%↑

LLY

1,043.44

-0.5%↓

JNJ

244.93

-0.74%↓

ABBV

231.82

+1.2%↑

NVS

167.49

+0.26%↑

MRK

123.99

+0.36%↑

Search

McKesson Corp

Chiusa

SettoreSettore sanitario

953.91 0.95

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

943.64

Massimo

958.4

Metriche Chiave

By Trading Economics

Entrata

40M

1.3B

Vendite

3B

106B

P/E

Media del settore

26.954

110.024

Rendimento da dividendi

0.33

Margine di Profitto

1.177

Dipendenti

43,000

EBITDA

374M

1.8B

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+3.42% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.33%

2.26%

Utili prossimi

7 mag 2026

Prossima data del Dividendo

1 apr 2026

Prossima data del' Ex Dividendo

2 mar 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

10B

115B

Apertura precedente

952.96

Chiusura precedente

953.91

Notizie sul Sentiment di mercato

By Acuity

54%

46%

288 / 351 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

McKesson Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 feb 2026, 23:07 UTC

Utili

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb 2026, 23:01 UTC

Utili

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb 2026, 22:59 UTC

Utili

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 feb 2026, 22:42 UTC

Utili

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 feb 2026, 22:24 UTC

Acquisizioni, Fusioni, Takeovers

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 feb 2026, 23:46 UTC

Discorsi di Mercato

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 feb 2026, 23:36 UTC

Discorsi di Mercato

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 feb 2026, 23:30 UTC

Discorsi di Mercato

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 feb 2026, 23:20 UTC

Discorsi di Mercato

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 feb 2026, 23:20 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

24 feb 2026, 23:16 UTC

Utili

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 feb 2026, 23:13 UTC

Utili

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 feb 2026, 23:12 UTC

Utili

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 feb 2026, 23:10 UTC

Utili

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 feb 2026, 23:10 UTC

Utili

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 feb 2026, 23:08 UTC

Utili

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 feb 2026, 23:07 UTC

Utili

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 feb 2026, 22:52 UTC

Utili

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb 2026, 22:46 UTC

Utili

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb 2026, 22:31 UTC

Acquisizioni, Fusioni, Takeovers

Warner Receives New Bid From Paramount -- 3rd Update

24 feb 2026, 22:29 UTC

Utili

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 feb 2026, 22:28 UTC

Utili

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 feb 2026, 22:27 UTC

Utili

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 feb 2026, 22:27 UTC

Utili

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 feb 2026, 22:25 UTC

Utili

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 feb 2026, 22:24 UTC

Utili

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 feb 2026, 22:23 UTC

Utili

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 feb 2026, 22:22 UTC

Utili

Woolworths Interim Dividend 45 Australian Cents/Share

24 feb 2026, 22:22 UTC

Utili

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 feb 2026, 22:21 UTC

Utili

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Confronto tra pari

Modifica del prezzo

McKesson Corp Previsione

Obiettivo di Prezzo

By TipRanks

3.42% in crescita

Previsioni per 12 mesi

Media 990.1 USD  3.42%

Alto 1,107 USD

Basso 885 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per McKesson Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

11 ratings

9

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

681.92 / 707.28Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

No Evidence

A lungo termine

No Evidence

Sentiment

By Acuity

288 / 351 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat